(Q39724856)

14 September 2017

Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells (English)

1 reference

14 September 2017

Maikel P Peppelenbosch

object named as

Maikel P Peppelenbosch

7

0 references

Dirk Hose

6

object named as

Dirk Hose

1 reference

14 September 2017

Gwenny M Fuhler

1

1 reference

14 September 2017

Mirjam Baanstra

2

1 reference

14 September 2017

Daniel Chesik

3

1 reference

14 September 2017

Rajesh Somasundaram

4

1 reference

14 September 2017

Anja Seckinger

5

1 reference

14 September 2017

Nico A Bos

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

20 March 2010

1 reference

Experimental Cell Research

14 September 2017

1 reference

14 September 2017

316

1 reference

14 September 2017

11

1 reference

14 September 2017

1816-1828

1 reference

Emerging therapies for multiple myeloma

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Autologous hematopoietic stem-cell transplantation for multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Characterization of clonogenic multiple myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

The paradox of response and survival in cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Regulation of plasma-cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Bone marrow microenvironment and the identification of new targets for myeloma therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

The generation and regulation of functional diversity of malignant plasma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Disturbed granulocyte macrophage-colony stimulating factor priming of phosphatidylinositol 3,4,5-trisphosphate accumulation and Rac activation in fMLP-stimulated neutrophils from patients with myelodysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Serine phosphorylation negatively regulates RhoA in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Cytoplasmic p21Cip1 Is Involved in Ras-induced Inhibition of the ROCK/LIMK/Cofilin Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Cytokine-induced F-actin reorganization in endothelial cells involves RhoA activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

An essential role for calmodulin in regulating human T cell aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

In Vitro and in Vivo Characterization of Molecular Interactions between Calmodulin, Ezrin/Radixin/Moesin, and L-selectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Cytohesin-1 regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with LFA-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Characterization of in vitro growth of multiple myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Minimal residual disease monitoring in multiple myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to hydroxyapatite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.03.013

10.1016/J.YEXCR.2010.03.013

7 January 2021

Identifiers

DOI

1 reference

release_zkkceyj3vbcmli4fdgqgnubd54

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zkkceyj3vbcmli4fdgqgnubd54

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference